Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |